Test Price
2,800 AED✅ Home Collection Available
Neurofibromatosis Type 1 (NF1) Gene Genetic Test in UAE | 2800 AED | Comprehensive NGS Analysis
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Collection and VIP Mobile Phlebotomy (available daily 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This test analyzes the entire NF1 gene using Next-Generation Sequencing to detect mutations causing Neurofibromatosis Type 1, a genetic disorder characterized by skin changes, nerve tumors, and increased cancer risk. It aids in diagnosis, familial risk assessment, and personalized management.
| Feature | Our NGS Test | Traditional Sanger Sequencing |
|---|---|---|
| Technology | Next‑Generation Sequencing (NGS) | Sanger Capillary Electrophoresis |
| Gene Coverage | Full NF1 gene – all exons, intron‑exon boundaries, and known deep intronic regions | Targeted specific exons or hotspot regions only |
| Turnaround Time | 3–4 weeks | 4–8 weeks for full gene coverage |
| Sensitivity | >99.9% for point mutations, small indels, and copy number variants | High sensitivity but limited to sequenced amplicons |
| Clinical Utility | Comprehensive mutation detection, including novel variants | Best for confirmatory testing of previously identified mutations |
Physician Insight & Safety Protocols
“I understand the weight of awaiting genetic results. This NGS test provides high sensitivity, but a negative result does not completely rule out all forms of NF1, and a positive finding must be correlated with your clinical symptoms and family history. Please review the full report with your genetic counselor or treating physician before making any health decisions.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠ Important Advisory
Do not discontinue prescribed medication without consulting your doctor. A negative result does not exclude all NF1 variants; clinical correlation is essential.
Exclusion Criteria
- Clotted or contaminated blood sample
- Prenatal diagnosis without prior DHA‑approved genetic counseling
- DNA extracted from non‑validated sources or without chain‑of‑custody
- Recent blood transfusion (within 4 weeks) may cause mixed chimerism
🚨 Emergency Red Flags
- Sudden painful enlargement of a neurofibroma
- New‑onset neurological deficits (weakness, vision loss, hearing loss)
- Signs of malignant transformation (plexiform neurofibroma growth, unexplained weight loss, night sweats)
- Severe headache with vomiting or seizures
Patient FAQ & Clinical Guidance
1. What is the accuracy of the NF1 gene NGS test?
With ISO‑accredited sequencing and 99.9% diagnostic sensitivity, this test reliably detects pathogenic NF1 mutations across all exons and splice sites. Every variant is confirmed by orthogonal methods when necessary.
2. How long does it take to receive results?
Results are typically delivered within 3 to 4 weeks, including comprehensive bioinformatics analysis and clinical interpretation by our molecular pathologists.
3. Is genetic counseling required before testing?
Yes, a pre‑genetic counseling session is mandatory to discuss implications, draw a pedigree, and ensure informed consent under UAE law.
4. What sample type is required for this test?
Peripheral whole blood is the standard specimen. VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection are available daily from 8 AM to 11 PM for your convenience.
5. Can this test detect all types of NF1 mutations?
NGS covers point mutations, small insertions/deletions, and copy number variants across the full NF1 coding region and splice sites. However, very large genomic rearrangements or deep intronic variants may require complementary testing.
UAE Regulatory & Data Privacy Adherence
This test is performed under the regulatory oversight of the Dubai Health Authority (DHA) Facility License No. 1143. All patient data is handled in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic information remains strictly confidential and is used solely for diagnostic and clinical management purposes.
Clinical & Logistical Metadata
| Test Name | Neurofibromatosis Type 1 (NF1) Gene Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral Whole Blood (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM – 11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | Q85.01 (Neurofibromatosis, type 1) |
| LOINC Code | 97736-2 (NF1 gene mutation analysis in Blood by Sequencing) |
| DHA Facility License & Laboratory Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | License: 1143 |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians